Prospect: Information for the User
Sertralina TecniGen 50 mg Film-Coated Tablets
Read this prospect carefully before starting to take this medication,because it contains important information for you.
5Storage of Sertralina TecniGen
6.Contents of the package and additional information
Sertralina TecniGen contains sertraline as the active ingredient. Sertraline belongs to a group of medications called Selective Serotonin Reuptake Inhibitors (SSRIs); these medications are used to treat depression and/or anxiety disorders.
Sertralina TecniGen can be used to treat:
Depression is a clinical disease with symptoms such as feelings of sadness, inability to sleep well or to enjoy life as one used to.
OCD and anxiety disorders are diseases linked to anxiety, with symptoms such as being constantly preoccupied with repeated ideas (obsessions) that lead to repetitive rituals (compulsions).
PTSD is a disorder that may occur after a very emotionally traumatic experience, and has some symptoms similar to depression and anxiety. Social anxiety disorder (social phobia) is an anxiety disorder. It is characterized by intense anxiety or anguish in social situations (for example: speaking to strangers, speaking in public, eating or drinking in front of others, or worrying about behaving in a shameful manner).
Your doctor has considered that this medication is suitable for treating your condition.
If you are unsure why you have been prescribed Sertralina TecniGen, you should consult your doctor.
Do not take Sertralina TecniGen:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Sertralina TecniGen.
Medicines are not always suitable for everyone. Before starting treatment with Sertralina TecniGen, tell your doctor if you have or have had any of the following circumstances:
Some medications in the group to which Sertralina TecniGen belongs (called ISRS/IRSN) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Restlessness/Acatisia
The use of sertraline has been associated with acatisia (unpleasant restlessness and a need to move, often accompanied by an inability to sit or stand still). This occurs more often during the first weeks of treatment. Increasing the dose may be harmful, so if you develop these symptoms, you should contact your doctor.
Withdrawal symptoms
When treatment is stopped, it is common for withdrawal symptoms to occur, particularly if treatment is stopped abruptly (see section 4 Possible side effects). The risk of withdrawal symptoms depends on the duration of treatment, the dose, and the rate at which the dose is reduced. Generally, these symptoms are mild or moderate. However, in some patients, they can be severe. These symptoms usually occur during the first days after stopping treatment. In general, these symptoms usually resolve on their own and usually resolve within two weeks. In some patients, they may last longer (2-3 months or more). It is recommended that when stopping treatment with sertraline, the dose be gradually reduced over a period of several weeks or even months, and always agree with your doctor on the best way to stop treatment.
Thoughts of suicide and worsening of your depression or anxiety
If you are depressed and/or have anxiety disorders, you may have thoughts of harming yourself or committing suicide. This may increase at the beginning of treatment with antidepressants, as all these medications take time to take effect, which is usually two weeks but can be longer.
It is more likely to happen:
If you have thoughts of harming yourself or committing suicide at any time, contact your doctor or go to the hospital immediately.
It may be helpful for you to explain to a close family member or friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You can also ask them to tell you if they think your depression or anxiety is getting worse, or if they are concerned about changes in your behavior.
Children and adolescents
Normally, sertraline should not be used to treat children and adolescents under 18 years old, except in the case of patients with obsessive-compulsive disorder. Young patients have a higher risk of adverse effects such as suicidal thoughts, suicidal thoughts, and hostility (mainly aggression, confrontational behavior, and irritable reaction) when treated with this class of medications. However, it is possible that your doctor may decide to prescribe Sertralina TecniGen to a patient under 18 years old if they consider it to be the most suitable option for the patient. If your doctor has prescribed Sertralina TecniGen to a patient under 18 years old and wants to discuss this decision, please return to your doctor. You should inform your doctor if any of the symptoms listed above appear or worsen when a patient under 18 years old is taking sertraline. At the same time, the long-term effects on safety and related to growth, maturity, and cognitive and behavioral development of sertraline in this age group have not yet been demonstrated.
Taking Sertralina TecniGen with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Some medications may affect how Sertralina TecniGen works, or Sertralina TecniGen itself may reduce the effectiveness of other medications you are taking at the same time.
The use of Sertralina TecniGen with the following medications may cause severe side effects
Inform your doctor if you are taking the following medications:
Taking Sertralina TecniGen with food, drinks, and alcohol
Sertralina TecniGen tablets can be taken with or without food.
Alcohol should be avoided while being treated with sertraline.
Do not take sertraline with grapefruit juice, as it may increase sertraline levels in your body.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before taking this medication.
Consult your doctor or pharmacist before using any medication.
If you take sertraline in the final stages of pregnancy, there may be an increased risk of excessive bleeding after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking sertraline so they can advise you.
The safety of sertraline in pregnant women has not been fully established. Sertraline should only be administered to pregnant women if, in the doctor's opinion, the benefits for the mother outweigh any possible risk to the fetus. Women of childbearing age who are being treated with sertraline should use an appropriate contraceptive method.
Ensure that your midwife and/or doctor know that you are taking Sertralina TecniGen. When taken during pregnancy, particularly in the last three months of pregnancy, medications like Sertralina TecniGen may increase the risk of a serious condition in newborns called persistent pulmonary hypertension of the newborn (PPHN), which makes the baby breathe faster and turn blue. These symptoms usually start within the first 24 hours after the baby is born. If this happens to your baby, contact your midwife and/or doctor immediately.
Your newborn baby may have other conditions, which usually manifest within the first 24 hours after birth. The symptoms include:
If your baby has any of these symptoms at birth, or you are concerned about your baby's health, consult your doctor or midwife for advice.
There is evidence that sertraline is excreted in breast milk. Therefore, sertraline can only be used in breastfeeding women if, in the doctor's opinion, the benefits for the mother outweigh any possible risk to the baby.
In animal studies, some medications like sertraline have been shown to reduce sperm quality. Theoretically, this could affect fertility, but the impact on human fertility has not yet been determined.
Driving and operating machinery
Psychotropic medications like sertraline can affect your ability to drive or operate machinery. Therefore, do not drive or operate heavy machinery until you know how this medication affects your ability to perform these activities.
Sertralina TecniGen contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is:
Adults:
Depression and Obsessive-Compulsive Disorder:
The commonly effective dose for depression and OCD is 50 mg per day. The daily dose can be increased by 50 mg at intervals of at least one week, and thus over several weeks. The maximum recommended dose is 200 mg per day.
Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder:The treatment should start with a dose of 25 mg per day, and increased to 50 mg per day after one week.
The daily dose can be increased at intervals of 50 mg over a period of several weeks. The maximum recommended dose is 200 mg per day.
Children and Adolescents:
Sertralina TecniGen should only be used to treat children and adolescents aged 6 to 17 years with OCD.
Obsessive-Compulsive Disorder:
Children aged 6 to 12 years:The recommended starting dose is 25 mg per day. After one week, your doctor may increase the dose to 50 mg per day. The maximum dose is 200 mg per day.
Adolescents aged 13 to 17 years:The recommended starting dose is 50 mg per day. The maximum dose is 200 mg per day.
If you have liver or kidney problems, inform your doctor and follow the instructions they give you.
Administration form:
Sertralina TecniGen tablets can be taken with or without food.
Take your medication once a day, either in the morning or at night.
Your doctor will indicate the duration of treatment with this medication. The duration will depend on the nature of your illness and your response to treatment. It may take several weeks for your symptoms to improve.The treatment of depression usually should continue for 6 months after improvement.
If you take more Sertralina TecniGen than you should
If you accidentally take an excessive amount of sertralina, contact your doctor or go to the nearest hospital emergency service. Always carry the medication packaging with you, even if it is empty.
You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
The symptoms of overdose may include drowsiness, nausea, vomiting, rapid heart rate, tremors, agitation, dizziness, and in rare cases, loss of consciousness.
If you forget to take Sertralina TecniGen
If you forget to take a dose, do not take it when you remember. Take the next dose when it is due.
Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Sertralina TecniGen
Do not stop treatment with Sertralina TecniGen unless your doctor tells you to. Your doctor will want to gradually reduce the dose of Sertralina TecniGen over several weeks before stopping it completely. If you stop treatment abruptly, you may experience adverse effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, feeling unwell, or feeling dizzy and trembling. If you experience any of these adverse effects, or any other during the interruption of your treatment with Sertralina TecniGen, please inform your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
The most common side effect is nausea. Side effects depend on the dose and often disappear as treatment continues.
Inform your doctor immediately
If you experience any of the following symptoms after taking this medication, as these symptoms can be serious.
The following side effects were observed in clinical trials in adults.
Very common side effects (can affect more than 1 in 10 people):
Insomnia, dizziness, drowsiness, headache, diarrhea, feeling of discomfort, dry mouth, ejaculation problems, and fatigue.
Common side effects (can affect up to 1 in 10 people):
Uncommon side effects (can affect up to 1 in 100 people):
Rare side effects (can affect up to 1 in 1,000 people):
Side effects of unknown frequency
Since the marketing of sertraline, the following side effects have been reported
Other side effects in children and adolescents
In clinical trialsin children and adolescents, side effects were generally similar to those reported in adults (see above). The most common side effects in children and adolescents were headache, insomnia, diarrhea, and nausea.
Symptoms that may appear when treatment is stopped
If you stop treatment abruptly, you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and tremors (see section 3. If you stop treatment withSertralinaTecniGen).
A higher risk of bone fracture has been observed in patients treated with this type of medication.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly to the Spanish System for the Vigilance of Medicinal Products for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging, after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Do not dispose of medications through drains or trash. Deposit the packaging and medications you no longer need at the SIGRE collection point at the pharmacy.Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Sertralina TecniGen
The other components are:
calcium phosphate dibasic, microcrystalline cellulose, sodium carboxymethylcellulose from potato, anhydrous colloidal silica, and magnesium stearate. The coating includes: polyvinyl alcohol, titanium dioxide (E171), polyethylene glycol 300, and talc.
Appearance of the product and content of the container
Sertralina TecniGen 50 mg is presented as coated tablets with a white film coating, round, convex, and scored, packaged in blisters.
It is presented in containers with 10, 14, 28, 30, 56, 60, or 500 tablets.
Only some sizes of containers may be commercially marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Tecnimede España, Industria Farmacéutica, S.A.
Avda. de Bruselas, 13, 3º D. Edificio América. Polígono Arroyo de la Vega,
28108 Alcobendas (Madrid) ESPAÑA
Responsible for manufacturing:
Atlantic Pharma - Produções Farmacêuticas, S.A.
Rua da Tapada Grande, nº 2, Abrunheira, 24710-189 Sintra
Portugal
This medicine is authorized in the member states of the European Economic Area with the following names:
Portugal: Sertralina Aserta 50 mg tablets
Spain: Sertralina TecniGen 50 mg coated tablets EFG
Last review date of this text: July 2022
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http:// www.aemps.gob.es
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.